Stockreport

Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer's Claims [Yahoo! Finance]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF The SEC said that Cassava made misleading statements about a clinical trial of its Alzheimer's disease drug. Cassava in the settlement neither confirmed nor denied the [Read more]